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ABSTRACT
The antioxidant activities of twelve naphthalene compounds containing (E)-1-((3-iodophenylimino)methyl) naphthalen-
2-ol (NAPH1), (E)-1-((3-bromophenylimino) methyl) naphthalen-2-ol (NAPH2), E)-1-((4-bromo-2-(trifluoromethoxy) 
phenylimino) methyl) naphthalen-2-ol, (E)-1-((4-bromo-2-(trifluoromethoxy) phenylimino) methyl)naphthalen-2-ol 
(NAPH3), (E)-1-((2-methoxy-5-(trifluoromethyl) phenylimino) methyl) naphthalen-2-ol (NAPH4), (E)-1-((naphthalen-2-
ylimino) methyl) naphthalen-2-ol (NAPH5), (E)-1-((2-bromo-3-methylphenylimino) methyl) naphthalen-2-ol (NAPH6), 
(E)-N-((2-ethoxynaphthalen-1-yl)methylene)-3-methylaniline (NAPH7), (E)-4-ethoxy-N-((2-ethoxynaphthalen-1-yl) 
methylene) aniline (NAPH8), (E)-N-((2-ethoxynaphthalen-1-yl) methylene) naphthalen-1-amine (NAPH9), (E)-1-(2,5-
difluorophenyl)-N-((2-ethoxynaphthalen-1-yl) methylene) methanamine (NAPH10), (E)-N-((2-ethoxynaphthalen-1-yl) 
methylene)-4-fluoroaniline (NAPH11), (E)-N-((2-ethoxynaphthalen-1-yl)methylene)-2-ethylaniline (NAPH12) were 
investigated in vitro by antioxidant activity (phosphomolybdenum assay), reducing power, H2O2 scavenging activity, 
metal chelating effects and lipid peroxidation. Scavenging activities of the naphthalen compounds were tested against 
1,1-diphenyl-2-picrylhydrazyl, hydroxyl and superoxide anion radicals. Most of them are potent antioxidant, radical 
superoxide anion scavengers and in vitro inhibition of lipid peroxidation. The compounds; NAPH5, NAPH10 and NAPH12 
were found to exhibit promising antioxidant proﬁles at 10 and 50 mM concentrations. Among these, NAPH5 at higher 
concentration was the most active compound in inhibiting lipid peroxidation as shown in the homogenates of kidney, 
heart and spleen. The presented results validate that NAPH5, NAPH10 and NAPH12 can be possessed as a source of 
antioxidant potential and a rich source of synthetic antioxidant for medicinal or foods. 
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ABSTRAK
Aktiviti antioksidan 12 sebatian naftalena yang merangkumi (E)-1-((3-iodofenilimino)metil) naftalen-2-ol (NAPH1), 
(E)-1-((3-bromofenilimino) metil) naftalen-2-ol (NAPH2), (E)-1-((4-bromo-2-(trifluorometosi) fenilimino) metil) naftalen-
2-ol, (E)-1-((4-bromo-2-(trifluorometosi) fenilimino) metil) naftalen-2-ol (NAPH3), (E)-1-((2-metosi-5-(trifluorometil) 
fenilimino) metil) naftalen-2-ol (NAPH4), (E)-1-((naftalen-2-fenilimino) metil) naftalen-2-ol (NAPH5), (E)-1-((2-bromo-
3-metilfenilimino) metil) naftalen-2-ol (NAPH6), (E)-N-((2-etosinaftalen-1-il) metilena)-3-metilanilina (NAPH7), (E)-
4-etosi-N-((2-etosinaftalen-1-il) metilena) anilina (NAPH8), (E)-N-((2-etosinaftalen-1-il) metilena) naftalen-1-amina 
(NAPH9), (E)-1-(2,5-difluorofenil)-N-((2-etosinaftalen-1-il) metilena) metanamina (NAPH10), (E)-N-((2-etosinaftalen-
1-yl) metilena)-4-fluoroanilina (NAPH11), (E)-N-((2-etosinaftalen-1-yl)metilena)-2-etilanilina (NAPH12) telah dikaji in 
vitro dengan menilai aktiviti antioksidan (asai phosphomolybdenum), kuasa penurunan, aktiviti pemangsa H2O2, kesan 
pengkelatan logam dan pengoksidaan lipid. Aktiviti pemangsa sebatian naftalena diuji ke atas 1,1-difenil-2-pikrilhidrazil, 
hidroksil and bahan radikal anion superoksida. Kebanyakan daripada sebatian tersebut adalah bahan antioksidan 
yang poten, pemangsa radikal anion superoksida and pehalang pengoksidaan lipid in vitro. Sebatian sperti NAPH5, 
NAPH10 and NAPH12 didapati menunjukkan proﬁl antioksidan yang memberangsangkan pada kepekatan 10 and 50 
mM. Antaranya, NAPH5 pada kepekatan yang lebih tinggi merupakan sebatian yang paling aktif dalam menghalang 
pengoksidaan lipid seperti yang ditunjukkan dalam homogenat ginjal, jantung dan limpa. Hasil kajian mengesahkan 
NAPH5, NAPH10 and NAPH12 boleh dijadikan sumber bahan antioksidan yang berpotensi dan juga sumber berguna 
kepada bahan antioksidan sintetik untuk tujuan perubatan atau pemakanan.
Kata kunci: Alkali Schiff; naftalena; aktiviti antioksidan; aktiviti pemangsa radical; penyekatan peroksidasi lipid
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INTRODUCTION
Schiff bases which are formed by condensation of 
primary carbonyl and amines compounds (aldehydes 
and ketones) and their transition metal complexes 
are very important organic compounds in medicinal 
and pharmaceutical field because of their biological 
applications including antibacterial, antitumor activity, 
antifungal, antioxidant, anti-inflammatory, anti-HIV, 
antihypertensive, anticonvulsant, herbicidal, antifilarial, 
insecticidal, anthelmintic and schistosomicidal activities 
because of their three-dimensional structural proﬁles and 
cationic character. It has been shown that azomethine 
linkage (C = N) of the schiff base provides an opportunity 
for the stupendous biological effect such as antifungal, 
antibacterial, antitumor and herbicidal activities (Taha et 
al. 2011). Schiff bases including naphthalenes are classiﬁed 
as a benzenoid polycyclic aromatic hydrocarbon including 
two fused benzene rings and do not contain heteroatoms 
or carry substituents (Tamer et al. 2014). Currently, schiff-
bases have been investigated as scavenging free radicals 
of reactive oxygen species to be developed as potential 
antioxidants. The free radical scavenging effects of the 
schiff base may be due to its imino group and substituent 
extending free radical delocalization (Ekennia et al.; 
Shrivastava et al. 2017). 
Antioxidant activity is a very important parameter used 
to characterize different chemical materials. Therefore, the 
antioxidant molecules have become one of the major areas 
of scientific research. They are extensively investigated for 
their capacity to protect organism and cell from damage 
caused by oxidative stress (Carocho & Ferreira 2013). The 
scientists become more interested in newly synthesized 
antioxidant compounds that could prevent harmful effects 
of oxidative processes or scavenge the radicals on cell. 
The discovery of novel antioxidants has gained a lot of 
attention in the last years by many researchers based on 
their potential activities in controlling or preventing the 
occurence of destructive diseases such as aging, cancer 
disorders and cardiovascular (Nandagokula et al. 2013). 
Recently, the newly synthesized compounds incorporating 
oxadiazole ring have been of widespread attention due 
to their diverse pharmacological properties such as 
antitumor activities, anti-inﬂammatory antimicrobial 
and antianalgesic (Al-Amiery 2012). Trolox, butylated 
hydroxytoluene (BHT), tert-butylhydroquinone (TBHQ) 
and butylated hydroxyanisole (BHA) in fat and oily foods 
were used as antioxidant supplements to prevent oxidative 
degradation. It was found that the standard antioxidants 
may cause carcinogenesis and liver damage in laboratory 
animals (Taha et al. 2011). Therefore, we attempted to 
determine whether naphthalene derivatives exhibit the 
antioxidant activity in the in vitro model assays related 
to doses and also evaluated the effects of heterocyclic 
substituents (phenyl, naphthyl, ethoxynaphthyl) on their 
activities. 
The report of literature survey reveals that there is no 
information available about the antioxidant properties of 
naphthalene derivatives. The main goal of the study was to 
evaluate the total antioxidant, reducing power, inhibition 
level of lipid peroxidation (LP), metal chelating, superoxide 
anion (O2
.-), hydroxyl radical (·OH), H2O2 and free radical 
(DPPH·) scavenging activities of naphthalene derivatives 
and also to compare the activities of these compounds with 
BHA, BHT, TBHQ, trolox and vitamin E commonly used in 
the pharmaceutical industry at different concentrations.
MATERIALS AND METHODS
CHEMICALS
3-(2-pyridyl)-5,6-bis (4-phenyl-sulphonic acid)-1,2,4-
triazine (ferrozine), ethylenediaminetetraacetic acid (EDTA), 
tween-20, sodium phosphate, ammonium molybdate, 
K3Fe(CN)6, thiobarbituric acid (TBA), malondialdehyde 
(MDA) in phenazine methosulphate (PMS), nicotinamide 
adenine dinucleotide (NADH), nitroblue tetrazolium (NBT), 
1,1-diphenyl-2-picryl-hydrazl (DPPH·), ferrous chloride, 
Na2S2O3, L-ascorbic acid, K2HPO4, KH2PO4, KI, FeSO4, 
vitamin E, tert-butylhydroquinone  (TBHQ), BHA, BHT and 
trolox were purchased from Sigma–Aldrich (Steinheim, 
Germany). All other chemicals in the assays used were 
research grade.
SYNTHESIS OF THE NAPHTHALENE DERIVATIVES
The naphthalene derivatives, NAPH1 (Akbal et al. 2012b), 
NAPH2 (Akbal et al. 2012a), NAPH3 (Kargılı et al. 
2013), NAPH4 (Alpaslan et al. 2015), NAPH5 (Tamer 
et al. 2014), NAPH6 (Yıldırım 2012), NAPH7 (Yıldırım 
et al. 2016), NAPH8 (Yıldırım 2012), NAPH9 (Yıldırım 
2012), NAPH10 (Pekdemir et al. 2013), NAPH11 (Yıldırım 
2012) and NAPH12 (Kargılı et al. 2012) were synthesized, 
and their antioxidant, radical scavenging activities and 
inhibition of lipid peroxidation were evaluated in the 
current study (Table 1).
ASSAY OF TOTAL ANTIOXIDANT
The total antioxidant activity of the naphthalene samples 
and standards (10 and 50 mM) was evaluated following the 
method given by Prieto et al. (1999) based on the reduction 
of Mo(VI) to Mo(V) by the naphthalenes or standards and 
the subsequent formation of specific green phosphate/
Mo(V) compounds. A reagent solution (28 mM sodium 
phosphate, 0.6 M sulfuric acid and 4 mM ammonium 
molybdate) were mixed with 0.3 ml of naphthalene 
compounds and standards. All samples were incubated in 
water bath at 95°C for 90 min and cooled down to 25°C. 
The absorbance of the green phosphomolybdenum complex 
was recorded at 695 nm. The higher the absorbance of 
naphthalene derivatives the more effective the antioxidant 
compound was.
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ASSAY OF REDUCING POWER
In this test, the reductant compounds cause the reduction 
of the Fe3+/ferricyanide complex to the Fe2+ form and 
the presence of Fe2+ can be monitored by measuring the 
absorbance at 700 nm (Oyaizu 1986). One ml samples 
(10-50 µM) were mixed with 0.2 M phosphate buffer (2.5 
ml, pH 6.6) and 2.5 ml of 1% K3Fe(CN)6 and the mixture 
was incubated in a water bath at 50°C for 20 min. Then, 
2.5 ml of 10% TCA was added. The 2.5 ml of the mixture 
was mixed with 2.5 ml water and 0.5 ml of 0.1% FeCl3. It 
is indicated that high absorbance of the sample had good 
reducing power under the reaction condition.
TABLE 1. Structures of the naphthalene derivatives used
   Compounds Structure    Compounds Structure
 NAPH1;  NAPH7;
 (E)-1-((3-iodophenyl-  (E)-N-((2-ethoxy-
 imino)methyl)-  naphthalene-1-yl)-
 naphthalene-2-ol  methylene)-3-methylaniline
 NAPH2;  NAPH8;
 (E)-1-((3-bromo-  (E)-4-ethoxy-N-((2-
 phenylimino)methyl)-  ethoxynaphthalene-1-
 naphthalene-2-ol  yl)methylene)aniline
 NAPH3;  NAPH9;
 (E)-1-((4-bromo-2-  (E)-N-((2-ethoxy-
 (trifluoromethoxy)-  naphthalen-1-yl)-
 phenylimino)methyl)-  methylene)naphthalene-
 naphthalene-2-ol  1-amine
 NAPH4;   NAPH10; 
 (E)-1-((2-methoxy-5-  (E)-1-(2,5-difluoro-
 (trifluoromethyl)-  phenyl)-N-((2-ethoxy
 phenylimino)methyl)-  naphthalene-1-yl)-
 naphthalene-2-ol  methylene)methanamine
 NAPH5;   NAPH11; 
 (E)-1-((naphthalen-2-  (E)-N-((2-ethoxy
 ylimino)methyl)-  naphthalene-1-yl)-
 naphthalene-2-ol  methylene)-4-fluoro-
   aniline
 NAPH6;  NAPH12; 
 (E)-1-((2-bromo-3-  (E)-N-((2-ethoxy-
 methylphenylimino)-  naphthalene-1-yl)-
 methyl)naphthalene-2-ol  methylene)-2-ethylaniline
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ASSAY OF METAL CHELATING
The ferrous ion chelating activity of naphthalene derivatives 
and standard antioxidants was assessed as described by 
Dinis (Dinis et al. 1994). Ferrozine can form complex 
with ferrozine-Fe2+, effectively. In the presence of other 
chelating compounds, this complex is disrupted. Therefore, 
the intensity of specific red colour of the complex allows 
the prediction level of the chelating activity. Briefly, 
different concentrations of samples were added to a 
solution of 2 mM FeCl2 (0.05 ml) and left for incubation at 
25°C. The reaction was initiated by the addition of 5 mM 
ferrozine (0.2 ml) and the mixture was shaken vigorously 
and incubated at 25°C for 10 min. The absorbance of 
the solution was measured at 562 nm. The activity was 
calculated by the formula; The metal chelating activity (%) 
= [(Ac-As)/Ac] × 100 from which Ac is the absorbance of 
control and As is the absorbance of the sample.
ASSAY OF SUPEROXIDE ANION SCAVENGING
The estimation of superoxide anion (O2
.-) scavenging 
activity was based on the assay described in literature 
(Nishikimi et al. 1972). Briefly, O2
.- is generated in PMS-
NADH systems by oxidation of NADH and evaluated by 
adding NBT. In this experiment, 1.0 ml of sample, 1.0 ml of 
NBT solution (156 mM NBT) and 1.0 ml of NADH solution 
(468 mM) were mixed in a test tube. The reaction was 
initiated by adding 100 ml of PMS solution (60 mM PMS) to 
the mixture. The mixture was incubated at 25°C for 5 min 
and absorbance was recorded at 532 nm. The activity was 
calculated according to the following formula: Inhibition 
(%) = [(Ac-As) / Ac] ×100 where Ac is the absorbance of the 
control and As is the absorbance of the sample.
ASSAY OF FREE RADICAL SCAVENGING
The electron donation activity of the naphthalene 
derivatives was measured by bleaching of the purple-
coloured solution of DPPH· according to the technique 
reported by Blois with a slight modification (Blois 1958). 
In this assay, the bleaching rate of a stable free radical 
(DPPH·) was monitored at a characteristic wavelength 
(517 nm) in the presence of naphthalene derivatives. The 
solutions of naphthalenes or standard antioxidants (10-
50 µM) were added to 0.5 ml of DPPH· (0.1 mM). The 
mixtures were incubated at 25°C and the absorbance was 
recorded at 517 nm. The free radical scavenging activity 
was calculated by the given formula: Inhibition (%) = (Ac 
– As) / As × 100 where As is the absorbance of the control 
and Ac is the absorbance in the presence of the sample.
ASSAY OF H2O2 SCAVENGING
The H2O2 scavenging activity of the naphthalene derivatives 
was measured according to slightly modified method given 
in the reference (Zhao et al. 2006). Briefly, 10 and 50 μM 
concentration of samples were mixed with 1 ml of H2O2 
(0.1 mM), 1 ml of 100 μl ammonium molybdate (3%), 10 
ml of H2SO4 (2 M) and 7 ml of KI (1.8 M), respectively. 
The mixed solution was titrated with Na2S2O3 (5 mM) until 
the yellow color disappeared. The H2O2 scavenging activity 
was calculated according to the following formula:
Inhibition (%) = (Vc – Vs) / Vc × 100 where Vc and Vs 
are volumes of the control and the sample, respectively.
ASSAY OF HYDROXYL RADICAL SCAVENGING
The scavenging activity of peroxide by the naphthalene 
derivatives was determined by slightly modified method 
given by Smirnoff & Cumbes (1989). In this assays, 
hydroxyl radical was produced by mixing H2O2 and FeSO4 
at room temperature. The mixture composed of 1 ml of 
FeSO4 (1.5 mM), 0.7 ml of H2O2 (6 mM), 0.3 ml sodium 
salicylate (20 mM) and naphthalenes compounds (10-50 
µM). The samples were incubated at room temperature 
for 1 h. The absorbance of the hydroxylated salicylate 
was measured at 562 nm against a blank. The hydroxyl 
scavenging activity was calculated using the following 
equation: Inhibition (%) = [1- (Ac –As) / A2] × 100 where 
Ac and As are the absorbances of the control and the sample, 
respectively.
ASSAY OF LIPID PEROXIDATION
The lipid peroxidation (LP) level of naphthalene compounds 
was determined by using the rat liver, lung, kidney, brain, 
heart and spleen homogenates in the presence of FeCl2-
ascorbic acid (Varshney & Kale 1990). Male Albino Wistar 
rats (200-220 g) were fed with a standard laboratory pellet 
and allowed to drink tap water ad libitum. The rats were 
starved for 24 h prior to execution by decapitation under 
anaesthesia. After applying heparin to the liver, the organs 
were perfused with ice-cold 0.9% NaCl (+ 4°C) to cleanse 
the blood and to eliminate any possible effects due to diurnal 
variation, immediately. The liver, lung, kidney, brain, heart 
and spleen were immediately removed and washed with 
ice-cold distilled water (+ 4°C) and homogenized with 
0.15 M Tris KCl (pH 7.4) in an all-glass homogenizer. 
The homogenate of each organ was centrifuged at + 4°C 
for 25 min at 15.000 × g to obtain cytosolic fraction. The 
protein contents of cytosolic fractions were determined at 
660 nm using BSA as the standards (Lowry et al. 1951). The 
LP level was measured by estimation of TBA as the level 
of nmoles of MDA formed per mg protein at 532 nm. An 
appropriate concentration of cytosolic sample was mixed 
with 0.15 M Tris KCl (pH 7.4), 30% TCA and 52 mM TBA 
in a final volume of 3.0 ml. The mixture was incubated in 
water bath at 90°C for 45 min, cooled immediately in an 
ice bath, and centrifuged at 5000 × g. The absorbance of 
clear supernatant solution was measured at 532 nm. MDA 
was used as standard. The results were defined as nmoles 
of MDA formed/mg cytosolic protein.
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STATISTICAL ANALYSIS
The data were presented as mean ± standard deviation 
(S.D.). Statistical analysis was conducted using SPSS (17.0) 
software. The results of activities were peformed using 
one-way ANOVA and followed by Tukey’s HSD test with α 
= 0.05. All assays were performed in triplicate.
RESULTS AND DISCUSSION
The antioxidant activities of NAPH1-12 were evaluated 
by several in vitro methods at various concentrations 
in order to compare the results with different standards 
and to establish the relationships between structure and 
antioxidant activity for each assay (Table 1-6).
ANTIOXIDANT ACTIVITY
This method is routinely applied in the samples to 
evaluate the total antioxidant capacity (Prieto et al. 
1999). The results indicated that naphthalene derivatives 
had the highiest antioxidant activity and exhibited the 
concentration and substitutent effects on the antioxidant 
activities (Govindhan et al. 2015). The heterocyclic ligands 
effectively pulling electron in the naphthalene rings had 
an effective increasing on antioxidant activity (Bala et al. 
2013). The results of the preliminary qualitative antioxidant 
activity of all the tested compounds were as listed in Table 
2. Different concentration of naphthalene derivatives and 
standards exhibited significant increased in the antioxidant 
activities (p < 0.05). It is revealed that NAPH3, 4, 5 and 
6 exhibited the potential antioxidant activity. Among 
these, NAPH6 appears to show the best antioxidant when 
compared with BHA, trolox, BHT and TBHQ. The increasing 
of the naphthalene functional group numbers as electron 
acceptor phenyl and naphthyl groups indicated the best 
antioxidant activity. The ligands inductively pulling 
electron from the naphthalene ring exhibited increasing 
on total antioxidant activity.
The order of activity was VIT E > NAPH6 > NAPH5 > 
NAPH4 > NAPH3 > BHA > NAPH8 > NAPH1 > NAPH12 
> NAPH2 > NAPH10 > trolox > BHT > NAPH11 > TBHQ 
> NAPH7 > NAPH9 in terms of phosphomolybdenum 
reduction potential at 50 μM (Table 2). 
REDUCING POWER
The presence of reductants causes the reduction of the 
Fe3+-ferricyanide complex to the Fe2+ in conformity with 
the measurements of the blue-color such as antioxidant 
substances in the naphthalene derivatives (Matsushita et al. 
2011). An increase in absorbance of the reaction mixture 
may indicate an increase in the reducing capacity due to an 
increase in the formation of the complex, Fe4[Fe(CN
−)6]3). 
The reducing power has been shown to exert antioxidant 
action by donating a hydrogen atom to break the free 
radical chain (Kiokias & Gordon 2004). The results of 
reducing power of of the naphthalenes, BHA, BHT, TBHQ, 
trolox and VIT E were evaluated at the concentrations of 
10 and 50 μM, asdepicted in the Table 2. Their reducing 
power capacities were found to be dose dependent except 
for the reducing power of NAPH2, NAPH6 and NAPH9. 
Due to the presence of substituted naphthyl containing 
hydroxy and naphthalene rings (electron withdrawing 
group), NAPH5 exhibited much better reducing power 
and had a higher absorbance value when compared to the 
other napthalene derivatives and standards. Table 2 shows 
that the reducing power capacity of samples in decreasing 
order order: NAPH5 > NAPH12 > BHA > BHT > trolox 
> NAPH8 > VIT E > TBHQ > NAPH11 > NAPH9 > 
NAPH10 > NAPH1 > NAPH3 > NAPH4 > NAPH7 > 
NAPH6 > NAPH2 at higher concentration (p < 0.05). 
While reductive properties of NAPH5 and NAPH12 were 
higher than the standard antioxidants at 50 μM, reductive 
capabilities of NAPH5 and NAPH12 were lower than the 
standards at 10 μM.
FREE RADICAL SCAVENGING ACTIVITY
DPPH· scavenging assay is a standard assay for evaluating 
free radical scavenging activity in a rapid technique 
compared with other assays of specific compounds (Polterait 
1997). DPPH· is a stable, deep purple color with free radical 
widely used to evaluate radical scavenging activity. The 
antioxidant reacts with DPPH· free radical (i.e., by providing 
hydrogen atom or by electron donation, conceivable), 
converting it to colorless 1,1-diphenyl-2-picrylhydrazine 
(DPPH2) when it is present in the medium. The degree of 
discoloration indicates the radical scavenging activity of 
the antioxidant in terms of their hydrogen donating property 
(Charef et al. 2015). Accordingly, scavenging capacity 
of naphthalene derivatives were measured following the 
decrease of absorbance at 517 nm. Percentage activity of 
naphthalenes at different concentrations were recorded and 
compared with the standards. The scavenging activity of all 
naphthalene derivative compounds were calculated (Table 
3) and found to be concentration-dependent significantly (p 
< 0.05). All synthesized naphthalene analogues exhibited 
lower scavenging activity than the standard antioxidants 
and showed moderate to excellent scavenging activities. 
The increasing order of free radical scavenging activity of 
synthesized analogues was as follows: trolox > TBHQ > 
VIT E > BHA > NAPH7 > NAPH10 > BHT > NAPH12 
> NAPH8 > NAPH1 > NAPH4 > NAPH9 > NAPH11 > 
NAPH6 > NAPH3 > NAPH5 > NAPH2 at 50 μM. On 
the basis of this observation, it can be suggested that the 
presence of electron-donating groups in the naphthalene 
moiety have an important influence on the quality of 
their radical scavenging activities at 10 μM and 50 μM. 
Among them, NAPH7 and NAPH10 compounds exhibited 
dominant free radical scavenging activities compared 
to BHT due to the presence of more electron donating 
groups.
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METAL CHELATING ACTIVITY
Iron accelerates lipid peroxidation by breaking down 
hydrogen and lipid peroxide forms (Haber & Weiss 
1934). In the presence of antioxidant chelating agents, 
the ferrozine-Fe2+ complex formation is prevented by the 
formation of the red color complex (Dinis et al. 1994). 
Changes in the color intensity allows the estimation of metal 
chelating capacity. Naphthalene derivatives interfered with 
the formation of Fe3+ or Fe2+-complex since they have the 
chelating activity to capture Fe2+ before ferrozine (Turan et 
al. 2016). Metal chelating activity of naphthalen-2-ol and 
2-ethoxynaphthalen containing phenylimino (NAPH1-6) 
and substituted aniline or naphthalyl (NAPH7-12) were 
compared. The activities of the naphthalenes were found to 
be concentration-dependent (Table 3). The metal chelating 
activity was lower than standards at 50 μM, signifigantly 
(p < 0.05) and the naphthalene ligands could be effective 
chelating agents for metal ions. The increasing order of the 
metal chelating activity of the samples was EDTA > BHT 
> trolox > BHA > VIT E > TBHQ > NAPH12 > NAPH10 
> NAPH11 > NAPH9 > NAPH1 > NAPH8 > NAPH7 
> NAPH2 > NAPH3 > NAPH5 > NAPH6 > NAPH4. 
The 2-ethoxynaphthalen analogues (NAPH10-12) and 
substituted naphalene (NAPH9) exhibited better metal 
chelating activity than the other synthesized compounds. 
TABLE 2. Total antioxidant activity by phosphomolybdenum method and reducing power of the naphthalene derivatives and 
standards at 10 and 50 μM. Each value represents mean ± SD, (n = 3), where * corresponds to p < 0.05.
  
Samples
     Antioxidant activiy*, 695 nm    Reducing power*, 700 nm
  10 μM 50 μM 10 μM 50 μM
 NAPH1 0.156 ± 0.010 0.179 ± 0.010 0.112 ± 0.001 0.115 ± 0.003
 NAPH2 0.178 ± 0.002 0.175 ± 0.012 0.097 ± 0.001 0.070 ± 0.011
 NAPH3 0.181 ± 0.006 0.184 ± 0.016 0.115 ± 0.001 0.113 ± 0.020
 NAPH4 0.183 ± 0.058 0.185 ± 0.002 0.092 ± 0.001 0.108 ± 0.024
 NAPH5 0.163 ± 0.005 0.188 ± 0.004 0.117 ± 0.002 0.217 ± 0.013
 NAPH6 0.149 ± 0.002 0.189 ± 0.005 0.102 ± 0.007 0.094 ± 0.022
 NAPH7 0.144 ± 0.012 0.156 ± 0.007 0.114 ± 0.003 0.104 ± 0.021
 NAPH8 0.156 ± 0.018 0.181 ± 0.014 0.116 ± 0.067 0.157 ± 0.014
 NAPH9 0.164 ± 0.013 0.156 ± 0.012 0.179 ± 0.012 0.121 ± 0.012
 NAPH10 0.188 ± 0.014 0.175 ± 0.010 0.115 ± 0.041 0.118 ± 0.022
 NAPH11 0.144 ± 0.006 0.169 ± 0.007 0.111 ± 0.012 0.123 ± 0.030
 NAPH12 0.164 ± 0.011 0.177 ± 0.013 0.133 ± 0.060 0.195 ± 0.011
 BHA 0.184 ± 0.005 0.184 ± 0.041 0.134 ± 0.018 0.194 ± 0.034
 BHT 0.178 ± 0.015 0.171 ± 0.012 0.176 ± 0.024 0.181 ± 0.025
 TBHQ 0.154 ± 0.006 0.167 ± 0.022 0.129 ± 0.021 0.151 ± 0.014
 Trolox 0.164 ± 0.022 0.173 ± 0.009 0.160 ± 0.011 0.168 ± 0.009
 VIT E 0.182 ± 0.002 0.191 ± 0.010 0.169 ± 0.008 0.167 ± 0.023
 Abbreviations: BHA; Butylated hydroxyanisol, BHT; Butylated hydroxytoluene,
 TBHQ; t-butyl-hydroxyquinone,  VIT E; Vitamin E
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SUPEROXIDE ANION SCAVENGING ACTIVITY
O2
.- generated by metabolic reactions in cells are the 
precursor to active free radicals that have the power to induce 
tissue damage and react with biological macromolecules. 
O2
.- radicals directly initiate lipid peroxidation, (Wickens 
2001). Therefore, it plays an important role in the formation 
of many reactive oxygen species such as singlet oxygen, 
hydroxyl radical and hydrogen peroxide which induce 
oxidative damage in proteins, lipids and DNA (Pietta 2000). 
The antioxidants are able to inhibit the production of O2
.- 
and the NBT-H2 formation is monitored via blue colored 
product (Dinis et al. 1994). The inhibiting percentage of 
O2
.- generation by naphthalenes and standards (10 and 50 
mM) was given in Table 4. The decreasing order of O2
.- 
scavenging activity was TBHQ > trolox > BHA > NAPH5 
> NAPH12 > VIT E > BHT > NAPH4 > NAPH3 > NAPH6 
> NAPH11 > NAPH8 > NAPH2 > NAPH10 > NAPH7 > 
NAPH9 > NAPH1, (p < 0.05) (Table 4). The compound 
NAPH5 bearing two naphthalyl groups (electron donating 
group) at trans position exhibited higher superoxide 
scavenging activity.
H2O2 SCAVENGING ACTIVITY
H2O2 is formed in vivo by antioxidant enzymes and behaves 
as a precursor to produce ·OH. The ·OH radicals react with 
most biomolecules, able to cross cell membrane, cause 
tissue damage and cell death (Oktay et al. 2003). The 
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percentage of H2O2 scavenging ability by the naphthalenes 
and the standards (BHA, TBHQ, BHT, trolox and VIT E) at 10 
and 50 mM were as shown in Table 4. NAPH1, NAPH3 
and NAPH7 exhibited higher H2O2 scavenging activity 
than the standards at 50 mM, (p < 0.05). The scavenging 
activity values of H2O2 were in the following order: NAPH1 
> NAPH3 > NAPH7 > BHA > TBHQ > NAPH8 > trolox 
> NAPH10 > NAPH11 > NAPH2 > NAPH12 > BHT > 
NAPH9 > NAPH5 > VIT E > NAPH4 > NAPH6. NAPH1 
(60%) and NADP3 (59%) bearing iodophenylimino and 
trifluoromethoxyphenylimino groups have significantly 
enhanced scavenging activity towards H2O2.
·OH SCAVENGING ACTIVITY
The ·OH, known as the most reactive of oxygen radicals 
can severely damage biomolecules such as proteins, lipids 
and nucleic acids (Yoshikawa et al. 1997). The activity of 
naphthalenes at different concentrations was assessed by 
their competitive ability with salicylic acid for ·OH radical 
in the ·OH generating-detecting system. The scavenging 
activity was found to be higher in NAPH10 comparing 
to the other naphthalene derivatives and to be in the order 
of NAPH10 > BHA > BHT > TBHQ > VIT E > trolox 
> NAPH11 > NAPH12 > NAPH9 > NAPH7 > NAPH1 
> NAPH8 > NAPH4 > NAPH6 > NAPH3 > NAPH5 
> NAPH2 at 50 mM (Table 4), (p < 0.05). NAPH10 
compound dominated ·OH radical scavenging activity 
compared to the standards due to its substituted difluoro 
group (electron withdrawing) at para position. The coupling 
of two difluoro groups and substituted ethoxynaphthyl 
enhanced the scavenging activity. The other naphthalenes 
exhibited moderate ·OH scavenging activity at the two 
different doses.
TABLE 3 Free radical scavenging (DPPH·) and metal chelating (Fe2+) activity (10 and 50 mM) of the naphthalene derivatives 
and standards (TBHQ, BHA, BHT, trolox and VIT E) at 10 and 50 mM. Each value represents mean ± SD, (n = 3),
where * corresponds to p < 0.05.
  
Samples
   Free radical scavenging activity*, %   Metal chelating activity*, %
  10 μM 50 μM 10 μM 50 μM
 NAPH1 65.49 ± 3.04 69.39 ± 0.21 52.81 ± 0.16 58.37 ± 0.08
 NAPH2 62.23 ± 2.86 65.25 ± 0.24 53.90 ± 1.37 55.05 ± 0.21
 NAPH3 65.29 ± 2.81 66.33 ± 0.65 27.76 ± 1.09 53.15 ± 0.60
 NAPH4 66.11 ± 3.38 69.11 ± 0.03 3.45 ± 0.55 9.84 ± 0.38
 NAPH5 60.69 ± 3.15 65.51 ± 0.07 15.30 ± 11.05 26.30 ± 0.42
 NAPH6 67.83 ± 3.56 66.50 ± 0.25 1.32 ± 0.46 12.99 ± 0.46
 NAPH7 76.43 ± 2.73 78.42 ± 0.01 58.47 ± 0.49 56.00 ± 0.28
 NAPH8 70.45 ± 2.80 73.90 ± 0.23 61.32 ± 0.32 56.23 ± 0.78
 NAPH9 68.51 ± 2.73 68.95 ± 0.09 59.82 ± 0.34 60.23 ± 1.70
 NAPH10 76.02 ± 2.72 76.22 ± 0.35 49.00 ± 1.86 61.62 ± 0.50
 NAPH11 67.01 ± 2.99 66.53 ± 0.18 54.98 ± 1.43 60.34 ± 0.93
 NAPH12 68.17 ± 3.02 74.00 ± 0.22 7.56 ± 0.51 61.85 ± 0.30
 BHA 80.55 ± 2.96 94.46 ± 0.10 85.96 ± 4.45 86.35 ± 0.38
 BHT 71.36 ± 2.89 74.76 ± 0.05 74.68 ± 5.48 91.53 ± 1.42
 TBHQ 91.89 ± 2.91 96.25 ± 0.01 48.81 ± 0.91 62.21 ± 3.70
 Trolox 96.15 ± 3.05 98.41 ± 0.04 82.60 ± 3.12 88.47 ± 6.00
 VIT E 77.80 ± 2.88 95.43 ± 0.17 62.21 ± 3.70 80.39 ± 4.58
 EDTA - - 81.28 ± 6.94 95.39 ± 3.71
  Abbreviations: BHA; Butylated hydroxyanisol, BHT; Butylated hydroxytoluene,
 TBHQ; t-butyl-hydroxyquinone, VIT E; Vitamin E
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ASSAY OF LIPID PEROXIDATION
A number of physical and chemical phenomena initiates the 
LP level which proceeds continuously in the presence of a 
suitable substrate until a scavenging defence mechanism 
occurs. Lipids and lipid-containing materials including 
phospholipids, cholesterol, polyunsaturated fatty acids, 
DNA and oxygen prone to peroxidation during processing 
and storage (Antolovich et al. 2002; Frankel 2014). LP, 
being a complex free radical chain process, involves 
an array of radicals and is measured by the amount of 
peroxide, the primary product of lipid oxidation, produced 
during the initial stages of oxidation. The effects of 
naphthalenes on LP level in the liver, lung, brain, kidney, 
spleen and heart homogenates were determined in vitro 
and the results are as shown in Tables 5 and 6. The extent 
of inhibition by the naphthalenes and standards were 
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TABLE 4. O2
.-, H2O2 and 
·OH scavenging activities of the naphthalene derivatives and standards (BHA, BHT, TBHQ, trolox and VIT E)
at 10 and 50 mM. Each value represents mean ± SD, (n = 3), where * corresponds to p < 0.05.
         Superoxide scavenging       H2O2 scavenging       
·OH radical scavenging
 Samples        activity*, %        activity*, %        activity*, %
  10 μM 50 μM 10 μM 50 μM 10 μM 50 μM
 NAPH2 45.93 ± 0.91 53.61 ± 0.61 41.88 ± 0.83 52.83 ± 2.93 18.51 ± 1.36 22.95 ± 3.59
 NAPH3 47.92 ± 0.56 61.08 ± 0.45 54.13 ± 1.39 59.81 ± 1.62 20.81 ± 1.41 30.22 ± 0.38
 NAPH4 59.71 ± 0.73 62.35 ± 0.55 12.50 ± 2.20 23.08 ± 0.97 24.35 ± 2.00 36.57 ± 1.31
 NAPH5 28.88 ± 1.73 69.72 ± 1.14 44.04 ± 1.67 49.23 ± 0.80 21.30 ± 1.85 28.99 ± 3.01
 NAPH6 46.89 ± 1.75 59.19 ± 0.82 11.06 ± 4.33 15.86 ± 0.88 25.46 ± 2.28 35.20 ± 0.40
 NAPH7 45.37 ± 0.85 49.60 ± 1.11 52.81 ± 0.83 54.88 ± 2.03 45.67 ± 1.34 53.35 ± 2.83
 NAPH8 50.57 ± 1.06 54.40 ± 0.75 43.37 ± 1.67 53.85 ± 1.44 43.84 ± 1.69 47.16 ± 3.82
 NAPH9 41.84 ± 0.94 47.73 ± 0.76 46.92 ± 2.71 51.15 ± 1.67 35.49 ± 0.45 55.47 ± 0.99
 NAPH10 44.78 ± 0.69 53.29 ± 0.45 47.12 ± 0.83 52.88 ± 0.83 60.79 ± 1.85 79.06 ± 1.33
 NAPH11 50.53 ± 1.30 56.35 ± 0.78 48.56 ± 0.83 52.88 ± 0.83 47.76 ± 3.86 69.12 ± 2.43
 NAPH12 50.06 ± 0.94 69.50 ± 0.55 46.44 ± 4.23 51.63 ± 1.44 48.45 ± 1.75 67.50 ± 0.56
 BHA 61.56 ± 1.33 70.15 ± 1.81 47.77 ± 0.83 54.33 ± 2.20 74.18 ± 0.01 77.22 ± 0.61
 BHT 65.78 ± 1.29 66.76 ± 2.20 50.00 ± 1.73 51.44 ± 3.53 70.77 ± 0.87 73.19 ± 0.15
 TBHQ 74.63 ± 0.72 83.82 ± 0.16 44.85 ± 1.44 54.33 ± 0.83 65.10 ± 8.93 71.68 ± 0.17
 Trolox 72.01 ± 0.48 75.99 ± 0.61 49.85 ± 1.44 53.52 ± 1.44 60.74 ± 3.09 69.71 ± 4.07
 VIT E 57.16 ± 0.92 68.70 ± 1.71 45.12 ± 2.73 47.67 ± 2.20 64.86 ± 3.37 71.54 ± 0.77
 Abbreviations: BHA; Butylated hydroxyanisol, BHT; Butylated hydroxytoluene, TBHQ; t-butyl-hydroxyquinone,  VIT E; Vitamin E
TABLE 5. The effects of the naphthalene derivatives of the LP level on liver, kidney and brain. Each value represents mean ± SD,
(n = 3), where * corresponds to p < 0.05.
 
Samples
       LP*,**, liver       LP*,**, kidney        LP*,**, brain
  10 μM 50 μM 10 μM 50 μM 10 μM 50 μM
 NAPH1 0.81 ± 0.03 1.12 ± 0.01 2.49 ± 0.01 2.24 ± 0.05 3.19 ± 0.04 2.81 ± 0.13
 NAPH2 0.94 ± 0.03 1.20 ± 0.02 2.49 ± 0.07 1.91 ± 0.03 3.65 ± 0.14 1.49 ± 0.09
 NAPH3 1.45 ± 0.00 1.19 ± 0.03 3.64 ± 0.05 2.30 ± 0.04 3.27 ± 0.05 4.62 ± 0.37
 NAPH4 0.78 ± 0.03 0.87 ± 0.01 2.33 ± 0.01 2.99 ± 0.01 4.08 ± 0.04 2.91 ± 0.02
 NAPH5 0.80 ± 0.20 1.02 ± 0.03 2.18 ± 0.11 1.90 ± 0.05 3.24 ± 0.04 2.58 ± 0.02
 NAPH6 1.05 ± 0.06 0.89 ± 0.01 3.05 ± 0.02 3.90 ± 0.17 3.74 ± 0.08 4.23 ± 0.24
 NAPH7 1.62 ± 0.00 0.99 ± 0.01 2.56 ± 0.02 2.71 ± 0.07 3.80 ± 0.06 3.25 ± 0.13
 NAPH8 0.82 ± 0.02 0.94 ± 0.03 1.93 ± 0.01 5.31 ± 0.03 2.72 ± 0.19 2.88 ± 0.02
 NAPH9 0.85 ± 0.04 0.50 ± 0.01 2.58 ± 0.04 2.43 ± 0.02 4.38 ± 0.36 2.23 ± 0.04
 NAPH10 0.83 ± 0.06 0.71 ± 0.01 2.17 ± 0.01 2.78 ± 0.02 2.78 ± 0.04 2.66 ± 0.10
 NAPH11 0.91 ± 0.02 0.60 ± 0.01 2.77 ± 0.02 3.15 ± 0.07 3.00 ± 0.12 2.15 ± 0.01
 NAPH12 0.53 ± 0.01 0.85 ± 0.00 3.29 ± 0.10 2.56 ± 0.31 3.09 ± 0.04 2.39 ± 0.04
 Trolox 1.59 ± 0.03 1.01 ± 0.01 8.54 ± 0.04 1.21 ± 0.08 2.55 ± 0.05 2.86 ± 0.07
 TBHQ 0.84 ± 0.01 0.66 ± 0.01 2.28 ± 0.01 2.14 ± 0.04 1.58 ± 0.01 3.92 ± 0.04
 BHT 4.40 ± 0.12 0.62 ± 0.00 2.23 ± 0.02 3.82 ± 0.88 3.07 ± 0.08 2.36 ± 0.01
 BHA 1.14 ± 0.08 1.10 ± 0.02 2.02 ± 0.02 2.63 ± 0.06 4.71 ± 0.13 4.08 ± 0.04
 VIT E  2.81 ± 0.03 0.53 ± 0.02 2.33 ± 0.05 2.99 ± 0.06 3.55 ± 0.06 3.94 ± 0,09
 **nmole MDA formed/mg protein
 Abbreviations: BHA; Butylated hydroxyanisol, BHT; Butylated hydroxytoluene, TBHQ; t-butyl-hydroxyquinone, VIT E; Vitamin E
C
om
po
un
d
C
om
po
un
d
Po
si
tiv
e 
co
nt
ro
l
Po
si
tiv
e 
co
nt
ro
l
Chap 6.indd   52 22/02/2018   11:39:11
53
TABLE 6. The effects of the naphthalene derivatives of the LP (lipid peroxidation) activity on lung, heart and spleen homogenates. 
Each value represents mean  ±  SD, (n = 3), where * corresponds to p < 0.05.
 
Samples
       LP*,**, lung       LP*,**, heart        LP*,**, spleen
  10 μM 50 μM 10 μM 50 μM 10 μM 50 μM
 NAPH1 1.61 ± 0.02 1.62 ± 0.03 0.97 ± 0.04 1.15 ± 0.05 2.88 ± 0.04 7.28 ± 0.21
 NAPH2 1.90 ± 0.01 2.03 ± 0.12 1.73 ± 0.02 0.92 ± 0.02 2.57 ± 0.03 1.44 ± 0.05
 NAPH3 2.17 ± 0.02 1.44 ± 0.02 1.27 ± 0.04 0.53 ± 0.01 1.60 ± 0.04 2.61 ± 0.08
 NAPH4 1.57 ± 0.05 1.27 ± 0.03 0.99 ± 0.02 0.93 ± 0.03 1.09 ± 0.01 1.02 ± 0.01
 NAPH5 1.51 ± 0.04 2.11 ± 0.02 1.22 ± 0.01 0.47 ± 0.02 1.10 ± 0.06 1.09 ± 0.01
 NAPH6 2.76 ± 0.07 1.34 ± 0.03 1.40 ± 0.02 0.92 ± 0.21 1.94 ± 0.01 1.43 ± 0.04
 NAPH7 1.47 ± 0.08 1.85 ± 0.18 1.14 ± 0.05 0.51 ± 0.01 1.88 ± 0.01 2.00 ± 0.01
 NAPH8 1.41 ± 0.04 1.64 ± 0.02 1.32 ± 0.06 0.73 ± 0.03 3.44 ± 0.09 2.15 ± 0.01
 NAPH9 1.49 ± 0.01 3.33 ± 0.07 1.55 ± 0.04 0.96 ± 0.01 1.57 ± 0.01 1.33 ± 0.06
 NAPH10 1.65 ± 0.04 1.35 ± 0.01 1.21 ± 0.07 0.63 ± 0.02 2.01 ± 0.27 1.50 ± 0.01
 NAPH11 1.65 ± 0.04 1.48 ± 0.06 0.99 ± 0.01 1.07 ± 0.02 1.87 ± 0.04 1.52 ± 0.01
 NAPH12 1.48 ± 0.05 1.39 ± 0.04 1.16 ± 0.04 1.24 ± 0.00 1.64 ± 0.02 1.19 ± 0.04 
 Trolox 1.32 ± 0.01 1.75 ± 0.09 1.27 ± 0.04 0.79 ± 0.02 1.13 ± 0.03 1.29 ± 0.03
 TBHQ 1.36 ± 0.03 1.83 ± 0.08 1.18 ± 0.04 0.67 ± 0.02 1.02 ± 0.08 1.59 ± 0.01
 BHT 1.29 ± 0.06 2.11 ± 0.06 1.19 ± 0.04 1.32 ± 0.03 2.29 ± 0.03 1.98 ± 0.01
 BHA 1.21 ± 0.04 2.28 ± 0.02 1.10 ± 0.09 0.66 ± 0.10 2.72 ± 0.01 2.54 ± 0.02
 VIT E  1.58 ± 0.16 1.44 ± 0.05 0.75 ± 0.01 1.35 ± 1.22 3.43 ± 0.01 2.87 ± 0.02
 **nmole MDA formed/mg protein
 Abbreviations: BHA; Butylated hydroxyanisol, BHT; Butylated hydroxytoluene, TBHQ; t-butyl-hydroxyquinone, VIT E; Vitamin E
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remarkable at 10 and 50 mM, (p < 0.05). Most of the 
naphthalene derivatives had the highest lipid peroxidation 
inhibition activity at 50 μM and the results were found in 
the liver (NAPH9 < VIT E < NAPH11 < BHT < TBHQ 
< NAPH10 < NAPH12 < NAPH4 < NAPH6 < NAPH8 < 
NAPH7 < trolox < NAPH5 < BHA < NAPH1 < NAPH3 
< NAPH2), in kidney (trolox < NAPH5 < NAPH2 < 
TBHQ < NAPH3 < NAPH1 < NAPH9 < NAPH12 < BHA 
< NAPH7 < NAPH10 < NAPH4 < VIT E < NAPH11 < 
BHT < NAPH6 < NAPH8), in brain (NAPH2 < NAPH11 
< NAPH9 < BHT < NAPH12 < NAPH5 < NAPH10 < 
NAPH1 < trolox < NAPH8 < NAPH4 < NAPH7 < TBHQ 
< VIT E < BHA < NAPH6 < NAPH3), in lung (NAPH4 
< NAPH6 < NAPH10 < NAPH12 < NAPH3 < VIT E < 
NAPH11 < NAPH1 < NAPH8 < Trolox < TBHQ < NAPH7 
< NAPH2 < BHT < NAPH5 < BHA < NAPH9), in heart 
(NAPH5 < NAPH7 < NAPH3 < NAPH10 < BHA < TBHQ 
< NAPH8 < trolox < NAPH6 < NAPH2 < NAPH4 < 
NAPH9 < NAPH11 < NAPH1 < NAPH12 < BHT < VIT 
E) and in spleen (NAPH4 < NAPH5 < NAPH12 < trolox 
< NAPH9 < NAPH6 < NAPH2 < NAPH10 < NAPH11 
< TBHQ < BHT < NAPH7 < NAPH8 < BHA < NAPH3 
< VIT E < NAPH1) at 50 mM. The antioxidant, reducing 
power, metal chelating, ·OH radical, H2O2, superoxide and 
free radical scavenging effects of napthalene derivatives 
on antioxidant activity and inhibitory effect on the lipid 
peroxidation (liver, kidney, brain, lung, heart, spleen) were 
not similar. Due to physical structure and mode of oxidation 
in assay systems, it is quite difficult to evaluate different 
effects of synthesized napthalene derivatives. Among 
the naphthalene, two substituted naphthyl analogues 
NAPH5 and NAPH9 exhibited excellent inhibition of lipid 
peroxidation followed by trifluoromethyl, methoxyl and 
hydroxyl analogues NAPH4 and followed by NAPH2 at 
50 μM concentration. The main role of antioxidants in the 
lipid medium is to delay or inhibit lipid peroxidation and to 
scavenge the peroxide radical to the hydro-peroxide before 
the radical chain propagation (Ates-Alagoz et al. 2006).
CONCLUSION
The results of this investigation indicated that the 
naphthalene derivatives had high antioxidant activities 
against various in vitro antioxidant systems assays and 
their activities were concentration-dependent (Sashidhara 
et al. 2010; Süzen 2007). We have confirmed that 
naphthalene derivatives containing different substituents 
(phenyl, naphthyl, ethoxynaphthyl, etoxyl and hydroxyl) 
were found to have better antioxidant and inhibition of 
lipid peroxidation comparing to standards (VIT E, BHA, 
TBHQ, BHT and trolox) at similar dose. NAPH3, 4, 5 
and 6 compounds made a reduction of improvement 
from Mo(VI) to Mo(V) in total antioxidant activity due 
to interacting with naphthalene-2-ol and phenyl in the 
naphthalene ring systems. These synthesized NAPH9 
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(liver), NAPH5 (kidney and heart), NAPH2 (brain) and 
NAPH4 (lung and spleen) were found to be most potent 
inhibitors of lipid peroxidation at 50 µM. The results of 
reducing power, metal chelating, free radical, superoxide 
and hydrogen peroxide scavenging activity at 10 and 50 
µM showed that all tested napthalene derivatives were 
significantly reactive. Therefore, they can be considered 
to be effectively useful as potential materials modulating 
oxidation for pharmaceutical and render promising 
antioxidant compounds.
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